Glaxis Capital Management, LLC Edwards Lifesciences Corp Transaction History
Glaxis Capital Management, LLC
- $52 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding EW
# of Institutions
1,378Shares Held
454MCall Options Held
3.86MPut Options Held
3.32M-
Vanguard Group Inc Valley Forge, PA53MShares$4.89 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY52.4MShares$4.84 Billion0.12% of portfolio
-
State Street Corp Boston, MA26.8MShares$2.47 Billion0.12% of portfolio
-
Brown Advisory Inc16.6MShares$1.54 Billion2.18% of portfolio
-
Alliancebernstein L.P. New York, NY16.4MShares$1.51 Billion0.57% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $57.1B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...